Jaguar Health Receives Complete Letter from FDA for Last of Four Major Technical Sections for the Company s Application for Conditional Approval of Canalevia (Crofelemer) for Chemotherapy-Induced Diarrhea (CID) in Dogs theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
The Veterinary Drug Approval Process and FDA Regulatory Oversight Seminar has been added to ComplianceOnline s offering.
SAN JOSE, CA, UNITED STATES, May 19, 2021 /EINPresswire.com/ ComplianceOnline, the world’s leading provider of training for regulated companies is holding a 3-day virtual seminar entitled ‘The Veterinary Drug Approval Process and FDA Regulatory Oversight.’ The seminar will be held June 9-11, 2021 (9:00 AM to 1:00 PM PDT).
The U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) is responsible for the approval of veterinary drug products intended for family pets, food-producing animals, and other animal species. This seminar will cover the process for obtaining federal government approval for marketing new animal drug products that are under the jurisdiction of the FDA, and also briefly covers animal products that are regulated by other federal agencies. For example, animal vaccines, animal disease diagnostic devices and some animal
Tetra Bio-Pharma Re-activates Veterinary Clinical Study in Companion Animals
ACCESSWIRE
04 May 2021, 21:43 GMT+10
A first of its kind synthetic cannabinoid medication to manage eye pain in the veterinary setting
OTTAWA, ON / ACCESSWIRE / May 4, 2021 /
Tetra Bio-Pharma Inc. ( Tetra or the Company )(TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a biopharmaceutical pioneer in immunomodulator drug discovery and development is pleased to announce that it has received authorization from the Veterinary Drugs Directorate of Health Canada for a one year extension to continue the clinical trial evaluating the safety, tolerability and potential efficacy of its veterinary ophthalmic drug, PPP-003v, in the treatment of indolent corneal ulcers in companion animals. Canine indolent corneal ulcers occur frequently in specific breeds of dogs
Tetra Bio-Pharma Re-activates Veterinary Clinical Study in Companion Animals theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
Launched Phase 2 study of drug known as micro PEA in December 2020
Developing drugs to treat gastrointestinal diseases in dogs and cats
FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) is a publicly-traded holding company that owns subsidiary FSD Pharma BioSciences Inc, a specialty biotech pharmaceutical R&D firm focused on developing multiple applications of its lead anti-inflammatory drug FSD-201.
The drug is now one of several therapeutics being advanced that could help reduce severe and deadly lung infection in coronavirus (COVID-19) patients.
Known as ultra-micronized PEA, the drug is a naturally occurring fatty acid similar to an endocannabinoid, one of a suite of molecules found in cannabis that targets endocannabinoid (CB2) receptors in the human body. The company holds exclusive worldwide rights to the drug that has been used for 40 years to fight respiratory infections - except in Italy and Spain, where PEA is prescribed as a medical-food supplement to treat chronic infla